搜尋結果
Amgen jumps after teasing weight-loss drug data, rival stocks fall
Reuters· 2 日前, opens new tab fell 2.3%. , opens new tab is conducting mid-stage studies of the injectable ...
Wegovy maker Novo Nordisk extends losses following first-quarter results
CNBC· 2 日前Shares of Danish pharmaceutical giant Novo Nordisk slid 2.5% on Friday, extending a 2.7% loss ...
Cittadella, The Tiny Italian Soccer Team That Unsettled Thierry Henry
Forbes· 1 日前Allow me to set the scene: UEFA Champions League soccer on live television, Kylian Mbappé’s PSG ...
Potential for Weight-Loss Drugs Boosts Eli Lilly
Bloomberg· 5 日前... soared as its brighter outlook for 2024 raised the potential ceiling for new weight< ... ...
Foxconn reiterates Q2 revenue to grow, posts record April sales
Reuters· 6 小時前Taiwan's Foxconn, the world's largest contract electronics maker and the biggest ...
Here Are the Obesity Drug Hopefuls Vying to Unseat Ozempic, Zepbound
Bloomberg· 2 日前Insatiable demand for weight-loss drugs has made the market so feverish that any positive ...
The Ozempic Effect: How a Weight Loss Wonder Drug Gobbled Up an Entire Economy
Bloomberg· 5 日前There is no escaping Ozempic and Wegovy. The diabetes and obesity drugs are a global ...
Today's campus protests aren't nearly as big or violent as those last century — at ...
Bastillepost· 2 日前In a way, the black-and-white Palestinian scarf draped over Hannah Sattler’s shoulders this ...
Escaping The Sunk Cost Trap: How Behavioral Economics Can Improve Your Daily Decisions
Forbes· 9 小時前Two stages with great live music running from lunch until well into the night, the amazing food for which this gem of the ...
We're booking profits in our largest position. Our discipline calls for another sale
CNBC· 6 日前... Jim Cramer's Charitable Trust will own 2,110 shares of WFC, decreasing its weighting ...